A generative explainable model for antimicrobial peptide prediction using bidirectional temporal convolutional neural network

Nature·Mar 17

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the use of artificial intelligence, including generative models and neural networks, to predict and optimize antimicrobial peptides. This work aims to combat drug-resistant infections and discover new peptides with antibacterial potency. The use of AI in this field may lead to advances in drug development and the fight against infectious diseases.

Full coverage

Harnessing generative AI for predicting and optimizing antimicrobial peptides against drug-resistant infections

Nature·May 22

Can artificial intelligence uncover the bioactive peptides’ benefits for human health and knowledge? A narrative review

Frontiers·Nov 26

AttBiLSTM_DE: enhancing anticancer peptide prediction using word embedding and an optimized attention-based BiLSTM framework | Scientific Reports

Nature·Dec 1

Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery

The Lancet·Sep 16

Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model

Science | AAAS·Mar 5

Recent advances in computational antimicrobial peptide discovery through big data, modeling, and artificial intelligence and their interplay in ushering the next golden era of drug development

Frontiers·Feb 28

A generative artificial intelligence approach for the discovery of antimicrobial peptides against multidrug-resistant bacteria

Nature·Oct 3

Leveraging artificial intelligence in the fight against infectious diseases

Science | AAAS·Jul 13

View original report at Nature ↗

Fetching the latest headlines…